STAAR Surgical ROE 2010-2023 | STAA

Current and historical return on equity (ROE) values for STAAR Surgical (STAA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
STAAR Surgical ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2023-12-31 $0.02B $0.39B 6.04%
2023-09-30 $0.02B $0.38B 5.97%
2023-06-30 $0.03B $0.35B 7.71%
2023-03-31 $0.03B $0.34B 10.20%
2022-12-31 $0.04B $0.34B 13.00%
2022-09-30 $0.04B $0.32B 14.21%
2022-06-30 $0.04B $0.30B 13.67%
2022-03-31 $0.03B $0.28B 12.95%
2021-12-31 $0.03B $0.26B 11.70%
2021-09-30 $0.02B $0.25B 10.28%
2021-06-30 $0.02B $0.24B 10.10%
2021-03-31 $0.01B $0.21B 5.70%
2020-12-31 $0.01B $0.20B 3.32%
2020-09-30 $0.01B $0.19B 5.25%
2020-06-30 $0.01B $0.18B 4.31%
2020-03-31 $0.01B $0.17B 7.77%
2019-12-31 $0.01B $0.16B 8.81%
2019-09-30 $0.01B $0.15B 5.69%
2019-06-30 $0.01B $0.14B 5.17%
2019-03-31 $0.01B $0.14B 4.45%
2018-12-31 $0.01B $0.13B 5.59%
2018-09-30 $0.00B $0.13B 5.95%
2018-06-30 $0.00B $0.05B 8.84%
2018-03-31 $0.00B $0.05B 2.38%
2017-12-31 $-0.00B $0.04B -5.03%
2017-09-30 $-0.00B $0.04B -5.19%
2017-06-30 $-0.01B $0.04B -13.25%
2017-03-31 $-0.01B $0.04B -15.89%
2016-12-31 $-0.01B $0.04B -31.58%
2016-09-30 $-0.01B $0.04B -33.99%
2016-06-30 $-0.01B $0.04B -33.55%
2016-03-31 $-0.01B $0.04B -33.12%
2015-12-31 $-0.01B $0.04B -18.06%
2015-09-30 $-0.01B $0.04B -23.53%
2015-06-30 $-0.01B $0.04B -25.97%
2015-03-31 $-0.01B $0.04B -25.64%
2014-12-31 $-0.01B $0.04B -22.36%
2014-09-30 $-0.01B $0.04B -17.18%
2014-06-30 $-0.00B $0.04B -7.50%
2014-03-31 $-0.00B $0.04B -2.61%
2013-12-31 $0.00B $0.04B 0.00%
2013-09-30 $0.00B $0.04B 0.00%
2013-06-30 $-0.00B $0.04B -3.01%
2013-03-31 $-0.00B $0.03B -3.10%
2012-12-31 $-0.00B $0.03B -3.15%
2012-09-30 $0.00B $0.03B 0.00%
2012-06-30 $0.00B $0.03B 0.00%
2012-03-31 $0.00B $0.03B 3.51%
2011-12-31 $0.00B $0.03B 3.77%
2011-09-30 $0.00B $0.03B 0.00%
2011-06-30 $-0.00B $0.03B -4.30%
2011-03-31 $-0.00B $0.02B -17.98%
2010-12-31 $0.00B $0.02B 0.00%
2010-09-30 $0.00B $0.02B 0.00%
2010-06-30 $-0.00B $0.02B -4.55%
2010-03-31 $0.00B $0.02B 0.00%
2009-12-31 $-0.01B $0.02B -30.00%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.267B $0.322B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.967B 18.46
Becton Dickinson (BDX) United States $67.638B 19.64
West Pharmaceutical Services (WST) United States $27.235B 46.04
Cardinal Health (CAH) United States $26.315B 15.82
Align Technology (ALGN) United States $22.499B 45.37
Cooper (COO) United States $17.972B 27.19
Labcorp (LH) United States $16.950B 14.47
Henry Schein (HSIC) United States $9.104B 15.75
DENTSPLY SIRONA (XRAY) United States $6.325B 16.67
Merit Medical Systems (MMSI) United States $4.182B 23.93
Patterson (PDCO) United States $2.331B 11.17
CONMED (CNMD) United States $2.237B 21.06
Atrion (ATRI) United States $0.708B 36.48
Lifevantage (LFVN) United States $0.086B 13.96
Pro-Dex (PDEX) United States $0.067B 25.33
Biolase (BIOL) United States $0.005B 0.00